Primary tabs

The Postpartum Depression Patient Journey

Postpartum Depression (PPD) Supplements

A series of articles on the patient journey and management challenges of PPD

The Postpartum Depression (PPD) Patient Journey

The first supplement in this series highlights the patient perspective in postpartum depression (PPD) from the perinatal period to treatment pathways. This supplement details how PPD is the most common medical complication of childbirth,1-5 with the identification of key risk factors described, as well as common challenges related to timely diagnosis and available treatment. To support this supplement, interviews were conducted with patients who experienced PPD during the prenatal and postpartum periods. Their insights are included throughout our supplement. The objectives of this supplement are to highlight the many perspectives of women affected by PPD, help to reduce the stigma around the disorder, and advocate that women affected by PPD have access to appropriate clinical care.


Postpartum Depression Supplement:
The Provider Perspective


Postpartum Depression Supplement:
The Payer Perspective


Please complete this form, then click submit.

References: 1. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013;347:1-9. 2. DeSisto CL, Kim SY, Sharma AJ. Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010.​/2014/13_0415.htm. Accessed May 1, 2018. 3. Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth. 2009;9(55):1-10. 4. Ko JY, Rockhill KM, Tong VT, et al. Trends in postpartum depressive symptoms—27 states, 2004, 2008, and 2012. MMWR. 2017;66(6):153-156.​/mm6606a1.htm. Accessed May 1, 2018. 5. Reddy UM, Rice MM, Grobman WA, et al. Serious maternal complications after early preterm delivery (24-33 weeks’ gestation). Am J Obstet Gynecol. 2015;213(4):538.e1-e9.

Terms and Conditions for Using this Site
© 2018 MediMedia, an ICON plc company.
All Rights Reserved.

© 2018 Sage Therapeutics, Inc. All rights reserved.
PP-US-PPD-0022 May 2018
This website is funded by Sage Therapeutics. All content is maintained by and property of Sage Therapeutics.